社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Picard Medical, Inc.(PMI)
盘后
0.2924
-0.02
-4.94%
19:25 EDT
0.3076
+0.0376
+13.93%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
垃圾股之王
·
05-05
$Picard Medical, Inc.(PMI)$
可以小进一手
$Picard Medical, Inc.(PMI)$ 可以小进一手
回复
评论
点赞
2
编组 21备份 2
分享
举报
港股挖掘机
·
03-24
“增长 + 物价” 双重绞杀!伊朗战事正在让全球经济 “喘不过气”
最新的商业调查显示,伊朗战事引发的外溢效应正重创经济增长动能并推高物价,全球经济初现同步震荡的迹象。 标普全球编制的多项采购经理人指数 (PMI) 在 3 月均出现明显下滑。周二公布的数据中,欧元区综合 PMI 降幅超出经济学家预期,澳大利亚综合指标骤降至萎缩区间,印度制造业活动则放缓至 2021 年以来最弱水平。 与此同时,多项价格指标大幅飙升:欧洲最大经济体德国的投入成本通胀率加速至三年多来最高水平,英国制造业的同类指标则创下 1992 年以来最大涨幅。 上述初步数据采集于 3 月下旬,反映出全球企业对伊朗冲突持续发酵、外溢效应不断扩大的日益悲观情绪。 综合来看,这些指数初步揭示了这场冲突对全球经济繁荣的冲击 —— 它已对那些关乎全球主要经济体运转的关键能源供应形成直接且毁灭性的打击。 各国政策制定者已对此高度警惕。欧洲央行行长拉加德上周表示,由美国总统特朗普发动袭击引发的伊朗战事,加剧了 “通胀上行风险与经济增长下行风险”。 欧洲央行与英国央行均转向鹰派警惕姿态,欧元区最快下月可能加息;日本央行也准备最快 4 月采取行动,而澳洲联储已连续第二次加息。 经济学家 Jamie Rush 称:“伊朗冲突爆发前,我们的全球增长追踪指标显示世界经济正积聚动能。但发达经济体最新 PMI 数据表明,这一初现的复苏势头,正被高企的油价、收紧的金融环境与低迷的市场信心联手扼杀。” 周二公布的数据暂未包含美国指标。截至目前,全球已发布的所有涵盖制造业与服务业的综合 PMI 均出现显著下滑。按发布时间排序,这些经济体包括澳大利亚、日本、印度、法国、德国、欧元区整体,以及英国。 欧元区制造业活动意外改善,但标普全球分析指出,这可能部分源于客户担忧供应中断而提前囤货。结合该区域服务业活动近乎停滞、综合指数创十个月新低的情况,整体形势不容乐观,尤其是价格指标显著攀升。 标普全球市场情报首席商业经
“增长 + 物价” 双重绞杀!伊朗战事正在让全球经济 “喘不过气”
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
TimothyX
·
03-03
与此同时,传统避险资产表现活跃:黄金价格上升2%,原油价格因供应担忧飙升7%,美元指数迎来数周来最强劲的一天,上升1%。 宏观经济数据:制造业复苏与通胀压力加剧 美股反弹的背后,有坚实的宏观数据支撑。2月份ISM制造业采购经理人指数(PMI)报52.4,连续第二个月高于50,标志制造业扩张,这是自2022年第四季度以来首次出现连续两个月扩张。
与此同时,传统避险资产表现活跃:黄金价格上升2%,原油价格因供应担忧飙升7%,美元指数迎来数周来最强劲的一天,上升1%。 宏观经济数据:制造业复苏与通胀压...
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
易方达香港
·
02-09
寰球易周谈 | 美国1月制造业PMI意外强劲扩张,墨西哥印度股市领跑全球
寰球易周谈 | 美国1月制造业PMI意外强劲扩张,墨西哥印度股市领跑全球
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
易方达香港
·
02-09
美国1月制造业PMI意外强劲扩张,非制造业扩张放缓
重要讯息:01) 易方达精选策略系列—易方达(香港)精选债券基金(「子基金」)须受限于一般巿况波动及子基金资产的其他固有因素。因此,阁下须承担无法收回投资于子基金的本金或可能损失大部分或全部投资的风险。02) 子基金主要投资于以离岸人民币、美元、欧元或港元计价的投资级别债务证券组成的投资组合,旨在为子基金产生资本增值以外的稳定收入流,从而达致长期资本增长。可能承担a) 有关债务证券的风险(包括信贷风险、有关信贷评级的风险、信贷评级调低风险、利率风险、估值风险、波动性及流动性风险、主权/政府债务风险、低于投资级别或未获评级的债务证券的风险及与投资于具有吸收亏损特点的债务工具相关的风险), b)集中风险, c) 新兴市场风险, d) 外汇风险, e) 有关销售及回购协议的风险, f) 有关反向回购协议的风险, g)人民币货币风险及人民币计价类别风险, h) 对冲人民币计价类别风险, i) 可转换债券风险, j) 有关股本证券的风险, k) 欧元区及欧洲国家风险, l) 「点心」债券风险。03) 子基金可在守则准许的范围内投资于衍生工具作对冲或投资目的,而在不利情况下,其运用金融衍生工具可能变得无效及/或致使子基金蒙受重大损失。04) 子基金可从子基金的资本中支付分派。投资者应注意,从资本中支付分派相当于退回或提取投资者的部分原投资额或归属于该原投资额的任何资本收益,而该等分派可能导致有关单位的资产净值实时减少。对冲单位类别的分派金额及资产净值可能受到有关对冲单位类别的类别货币与子基金的基础货币的利率差异之不利影响,导致从资本中支付的分派金额有所增加,以及因此相对其他非对冲单位类别的资本流失更大。05) 除非中介人于销售基金时已向阁下解释经考虑阁下的财务情况、投资经验及目标后,此基金是适合阁下的,阁下不应投资在子基金。06)&nb
美国1月制造业PMI意外强劲扩张,非制造业扩张放缓
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
我是一只小明
·
02-01
1月制造业PMI:需求疲弱,但价格开始通胀
考虑到2026年开始正儿八经会有经济复苏的预期,所以部分宏观数据有必要恢复跟踪,尤其是制造业大国的制造业PMI。1月制造业PMI为49.3,较上月的50.1下降0.8重回萎缩,一年以来扩张区间(50以上)露头就秒。 细分数据(50以上扩张,50以下萎缩): 生产指数:51.7→50.6,制造业生产大部分时间保持扩张,只是扩张的速度时快时慢; 新订单:50.8→49.2,需求侧的订单指数每次进入扩张区间都感恩戴德,但大部分是露头就秒,且内需也出现明显回落; 新出口订单:49.0→47.8,出海需求持续处于萎靡状态; 原材料购进价格53.1→56.1,出厂价格48.9→50.6,原材料库存47.8→47.4,产成品库存48.2→48.6,原材料价格上涨自去年7月开始反馈在PMI数据上,1月显著加速,需要注意的是,出厂价格亦在1月被带动重回上涨,这是20个月来首次出现通胀信号,同时原材料库存在持续去化。 按企业规模看,大型企业50.8→50.3,中型企业49.8→48.7,小型企业48.6→47.4,大型企业在扩张中放缓,而中小型企业一直在水深中火热。 由于1月属于部分制造业的传统淡季,又有春节备货的干扰,数据借口很多,带来了PMI的又一次滑落,但需求不足仍然是主要矛盾,无论是旷日持久的外需订单萎缩,还是疲弱的内需,这是无法回避的。 1月PMI唯一的亮点是给PPI出力了,价格终于开始传导了!由于需求是偏弱的状态,大部分原因是原材料的炸裂涨价,但结果就是这个结果。至于本文开头提到的经济复苏预期,暂时还没有信号,需求疲弱+产品通胀,这似乎对应了另一个名词。 后续关注需求是否改善,价格传导是否持续。
1月制造业PMI:需求疲弱,但价格开始通胀
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
我是一只小明
·
02-01
1月制造业PMI:需求疲弱,但价格开始通胀
考虑到2026年开始正儿八经会有经济复苏的预期,所以部分宏观数据有必要恢复跟踪,尤其是制造业大国的制造业PMI。1月制造业PMI为49.3,较上月的50.1下降0.8重回萎缩,一年以来扩张区间(50以上)露头就秒。 细分数据(50以上扩张,50以下萎缩): 生产指数:51.7→50.6,制造业生产大部分时间保持扩张,只是扩张的速度时快时慢; 新订单:50.8→49.2,需求侧的订单指数每次进入扩张区间都感恩戴德,但大部分是露头就秒,且内需也出现明显回落; 新出口订单:49.0→47.8,出海需求持续处于萎靡状态; 原材料购进价格53.1→56.1,出厂价格48.9→50.6,原材料库存47.8→47.4,产成品库存48.2→48.6,原材料价格上涨自去年7月开始反馈在PMI数据上,1月显著加速,需要注意的是,出厂价格亦在1月被带动重回上涨,这是20个月来首次出现通胀信号,同时原材料库存在持续去化。 按企业规模看,大型企业50.8→50.3,中型企业49.8→48.7,小型企业48.6→47.4,大型企业在扩张中放缓,而中小型企业一直在水深中火热。 由于1月属于部分制造业的传统淡季,又有春节备货的干扰,数据借口很多,带来了PMI的又一次滑落,但需求不足仍然是主要矛盾,无论是旷日持久的外需订单萎缩,还是疲弱的内需,这是无法回避的。 1月PMI唯一的亮点是给PPI出力了,价格终于开始传导了!由于需求是偏弱的状态,大部分原因是原材料的炸裂涨价,但结果就是这个结果。至于本文开头提到的经济复苏预期,暂时还没有信号,需求疲弱+产品通胀,这似乎对应了另一个名词。 后续关注需求是否改善,价格传导是否持续。
1月制造业PMI:需求疲弱,但价格开始通胀
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
易方达香港
·
01-26
美国1月PMI增速偏弱,消费显韧性但储蓄承压
重要讯息:01) 易方达精选策略系列—易方达(香港)精选债券基金(「子基金」)须受限于一般巿况波动及子基金资产的其他固有因素。因此,阁下须承担无法收回投资于子基金的本金或可能损失大部分或全部投资的风险。02) 子基金主要投资于以离岸人民币、美元、欧元或港元计价的投资级别债务证券组成的投资组合,旨在为子基金产生资本增值以外的稳定收入流,从而达致长期资本增长。可能承担a) 有关债务证券的风险(包括信贷风险、有关信贷评级的风险、信贷评级调低风险、利率风险、估值风险、波动性及流动性风险、主权/政府债务风险、低于投资级别或未获评级的债务证券的风险及与投资于具有吸收亏损特点的债务工具相关的风险), b)集中风险, c) 新兴市场风险, d) 外汇风险, e) 有关销售及回购协议的风险, f) 有关反向回购协议的风险, g)人民币货币风险及人民币计价类别风险, h) 对冲人民币计价类别风险, i) 可转换债券风险, j) 有关股本证券的风险, k) 欧元区及欧洲国家风险, l) 「点心」债券风险。03) 子基金可在守则准许的范围内投资于衍生工具作对冲或投资目的,而在不利情况下,其运用金融衍生工具可能变得无效及/或致使子基金蒙受重大损失。04) 子基金可从子基金的资本中支付分派。投资者应注意,从资本中支付分派相当于退回或提取投资者的部分原投资额或归属于该原投资额的任何资本收益,而该等分派可能导致有关单位的资产净值实时减少。对冲单位类别的分派金额及资产净值可能受到有关对冲单位类别的类别货币与子基金的基础货币的利率差异之不利影响,导致从资本中支付的分派金额有所增加,以及因此相对其他非对冲单位类别的资本流失更大。05) 除非中介人于销售基金时已向阁下解释经考虑阁下的财务情况、投资经验及目标后,此基金是适合阁下的,阁下不应投资在子基金。06)&nb
美国1月PMI增速偏弱,消费显韧性但储蓄承压
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
等也是一种策略 如何等在哪里等
·
01-18
📊 下周(1/19 - 23)重要经济指标与经济事件 📈 【1月19日(周一)】 美国市场休市(马丁·路德·金纪念日)🇺🇸 10:00 🇨🇳 中国 - 季度国内生产总值(GDP) 📈🔍 18:00 🇪🇺 欧元区 - 消费者物价调和指数(HICP) 🌐 达沃斯世界经济论坛 💼🏔️ 🌐 IMF世界经济展望 📊 【1月20日(周二)】 15:00 🇬🇧 英国 - 失业保险申请件数 📱 美国企业财报:Netflix[ $NFLX ] 【1月21日(周三)】 15:00 🇬🇧 英国 - 消费者物价指数(CPI) 23:00 🇺🇸 美国 - 成屋待完成销售指数 📱 美国企业财报: Johnson & Johnson[ $JNJ ] 【1月22日(周四)】 07:50 🇯🇵 日本 - 贸易统计 20:30 🇪🇺 欧元区 - 欧洲央行(ECB)理事会会议纪要 21:30 🇺🇸 美国 - 季度实际国内生产总值(GDP) 21:30 🇺🇸 美国 - 个人消费支出(PCE平减指数) 📈🔍 21:30 🇺🇸 美国 - 首次申请失业救济人数 📱 美国企业财报: 英特尔(Intel)[ $INTC ] 【1月23日(周五)】 07:30 🇯🇵 日本 - 全国消费者物价指数(CPI) 11:00 🇯🇵 日本 - 日本央行会议结束 💰🔍 13:00 🇸🇬 新加坡 - 消费者物价指数(CPI) 14:30 🇯🇵 日本 - 日本央行行长例行新闻发布会 🎙️💹 15:00 🇬🇧 英国 - 零售销售额 17:00 🇪🇺 欧元区 - 采购经理人指数(PMI) 17:30 🇬🇧 英国 - 采购经理人指数(PMI) 22:45 🇺🇸 美国 - 采购经理人指数(PMI) ※以上时间均为北京时间
📊 下周(1/19 - 23)重要经济指标与经济事件 📈 【1月19日(周一)】 美国市场休市(马丁·路德·金纪念日)🇺🇸 10:00 🇨🇳 中国 - 季度国...
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
锐信资本
·
01-16
美国两个制造业PMI数据的差异
美国两个制造业PMI数据的差异
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
公司概况
公司名称
Picard Medical, Inc.
所属市场
AMEX
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.picardmedical.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Picard Medical, Inc.于2021年4月8日在特拉华州注册成立。该公司作为一家控股公司,拥有SynCardia Systems, LLC(“SynCardia”)100%的权益。业务运营由SynCardia进行。SynCardia是一家医疗技术公司,生产和销售唯一经美国食品和药物管理局(“FDA”)和加拿大卫生部批准的全人工心脏(“TAH”),它完全取代了衰竭的人类心脏的功能。SynCardia还在医疗技术方面进行更多的研究和进步,包括下一代完全可植入和无驱动的心脏—Emperor TAH。
06-03 12:00
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
06-02 12:00
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
06-01 12:00
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
05-29
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
05-22
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
05-20
招股说明书
Form S-1 - General form for registration of securities under the Securities Act of 1933
Form S-1 - General form for registration of securities under the Securities Act of 1933
05-15
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05-15
[修订]年度报告
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
05-11
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
05-05
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
05-04
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
05-04
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
05-01
[修订]招股说明书
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
05-01
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
05-01
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
分时
5日
日
周
月
数据加载中...
最高
0.3740
今开
0.3300
量比
1.35
最低
0.2919
昨收
0.2700
换手率
1050.66%
热议股票
{"pagemeta":{"title":"Picard Medical, Inc.(PMI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Picard Medical, Inc.(PMI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Picard Medical, Inc.,PMI,Picard Medical, Inc.股票,Picard Medical, Inc.股票老虎,Picard Medical, Inc.股票老虎国际,Picard Medical, Inc.行情,Picard Medical, Inc.股票行情,Picard Medical, Inc.股价,Picard Medical, Inc.股市,Picard Medical, Inc.股票价格,Picard Medical, Inc.股票交易,Picard Medical, Inc.股票购买,Picard Medical, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Picard Medical, Inc.(PMI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Picard Medical, Inc.(PMI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"community","symbol":"PMI","data":{"stockData":{"symbol":"PMI","market":"US","secType":"STK","nameCN":"Picard Medical, Inc.","latestPrice":0.3076,"timestamp":1780516800000,"preClose":0.27,"halted":0,"volume":236742444,"hourTrading":{"tag":"盘后","latestPrice":0.2924,"preClose":0.3076,"latestTime":"19:25 EDT","volume":2415847,"amount":724193.3819112999,"timestamp":1780529106821,"change":-0.0152,"changeRate":-0.049415,"amplitude":0.089077},"delay":0,"changeRate":0.13925925925925914,"floatShares":22532700,"shares":92349845,"eps":-0.376,"marketStatus":"盘后交易","change":0.0376,"latestTime":"06-03 19:25:13 EDT","open":0.33,"high":0.374,"low":0.2919,"amount":80194395.8972484,"amplitude":0.304074,"askPrice":0.306,"askSize":1540,"bidPrice":0.2917,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.376,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1780531200000},"marketStatusCode":4,"adr":0,"listingDate":1756440000000,"exchange":"AMEX","adjPreClose":0.27,"preHourTrading":{"tag":"盘前","latestPrice":0.3299,"preClose":0.27,"latestTime":"09:29 EDT","volume":57401157,"amount":19614270.388846982,"timestamp":1780493399999,"change":0.0599,"changeRate":0.221852,"amplitude":0.403704},"postHourTrading":{"tag":"盘后","latestPrice":0.2924,"preClose":0.3076,"latestTime":"19:25 EDT","volume":2415847,"amount":724193.3819112999,"timestamp":1780529106821,"change":-0.0152,"changeRate":-0.049415,"amplitude":0.089077},"volumeRatio":1.353813},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.560973537858616","cardData":[{"tweetId":"560973537858616","author":{"authorId":"3562241343825358","idStr":"3562241343825358","name":"垃圾股之王","avatar":"https://static.tigerbbs.com/41f0262aa3b4037fd9c99257dd2e64d2","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":52,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/PMI\">$Picard Medical, Inc.(PMI)$</a> 可以小进一手","plainDigest":"$Picard Medical, Inc.(PMI)$ 可以小进一手","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1777988131464,"gmtModify":1777988133300,"symbols":["PMI"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":567,"likeCount":2,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/560973537858616","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":37,"displayRows":4,"foldSize":0,"authorId":"3562241343825358"}]},{"cardType":"TWEET","cardId":"TWEET.546146669728224","cardData":[{"tweetId":"546146669728224","author":{"authorId":"3524105790854316","idStr":"3524105790854316","name":"港股挖掘机","avatar":"https://static.tigerbbs.com/7ad7f6521dbd218dc1b2d938da24ac61","userType":8,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":1660,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"“增长 + 物价” 双重绞杀!伊朗战事正在让全球经济 “喘不过气”","digest":"最新的商业调查显示,伊朗战事引发的外溢效应正重创经济增长动能并推高物价,全球经济初现同步震荡的迹象。 标普全球编制的多项采购经理人指数 (PMI) 在 3 月均出现明显下滑。周二公布的数据中,欧元区综合 PMI 降幅超出经济学家预期,澳大利亚综合指标骤降至萎缩区间,印度制造业活动则放缓至 2021 年以来最弱水平。 与此同时,多项价格指标大幅飙升:欧洲最大经济体德国的投入成本通胀率加速至三年多来最高水平,英国制造业的同类指标则创下 1992 年以来最大涨幅。 上述初步数据采集于 3 月下旬,反映出全球企业对伊朗冲突持续发酵、外溢效应不断扩大的日益悲观情绪。 综合来看,这些指数初步揭示了这场冲突对全球经济繁荣的冲击 —— 它已对那些关乎全球主要经济体运转的关键能源供应形成直接且毁灭性的打击。 各国政策制定者已对此高度警惕。欧洲央行行长拉加德上周表示,由美国总统特朗普发动袭击引发的伊朗战事,加剧了 “通胀上行风险与经济增长下行风险”。 欧洲央行与英国央行均转向鹰派警惕姿态,欧元区最快下月可能加息;日本央行也准备最快 4 月采取行动,而澳洲联储已连续第二次加息。 经济学家 Jamie Rush 称:“伊朗冲突爆发前,我们的全球增长追踪指标显示世界经济正积聚动能。但发达经济体最新 PMI 数据表明,这一初现的复苏势头,正被高企的油价、收紧的金融环境与低迷的市场信心联手扼杀。” 周二公布的数据暂未包含美国指标。截至目前,全球已发布的所有涵盖制造业与服务业的综合 PMI 均出现显著下滑。按发布时间排序,这些经济体包括澳大利亚、日本、印度、法国、德国、欧元区整体,以及英国。 欧元区制造业活动意外改善,但标普全球分析指出,这可能部分源于客户担忧供应中断而提前囤货。结合该区域服务业活动近乎停滞、综合指数创十个月新低的情况,整体形势不容乐观,尤其是价格指标显著攀升。 标普全球市场情报首席商业经","plainDigest":"最新的商业调查显示,伊朗战事引发的外溢效应正重创经济增长动能并推高物价,全球经济初现同步震荡的迹象。 标普全球编制的多项采购经理人指数 (PMI) 在 3 月均出现明显下滑。周二公布的数据中,欧元区综合 PMI 降幅超出经济学家预期,澳大利亚综合指标骤降至萎缩区间,印度制造业活动则放缓至 2021 年以来最弱水平。 与此同时,多项价格指标大幅飙升:欧洲最大经济体德国的投入成本通胀率加速至三年多来最高水平,英国制造业的同类指标则创下 1992 年以来最大涨幅。 上述初步数据采集于 3 月下旬,反映出全球企业对伊朗冲突持续发酵、外溢效应不断扩大的日益悲观情绪。 综合来看,这些指数初步揭示了这场冲突对全球经济繁荣的冲击 —— 它已对那些关乎全球主要经济体运转的关键能源供应形成直接且毁灭性的打击。 各国政策制定者已对此高度警惕。欧洲央行行长拉加德上周表示,由美国总统特朗普发动袭击引发的伊朗战事,加剧了 “通胀上行风险与经济增长下行风险”。 欧洲央行与英国央行均转向鹰派警惕姿态,欧元区最快下月可能加息;日本央行也准备最快 4 月采取行动,而澳洲联储已连续第二次加息。 经济学家 Jamie Rush 称:“伊朗冲突爆发前,我们的全球增长追踪指标显示世界经济正积聚动能。但发达经济体最新 PMI 数据表明,这一初现的复苏势头,正被高企的油价、收紧的金融环境与低迷的市场信心联手扼杀。” 周二公布的数据暂未包含美国指标。截至目前,全球已发布的所有涵盖制造业与服务业的综合 PMI 均出现显著下滑。按发布时间排序,这些经济体包括澳大利亚、日本、印度、法国、德国、欧元区整体,以及英国。 欧元区制造业活动意外改善,但标普全球分析指出,这可能部分源于客户担忧供应中断而提前囤货。结合该区域服务业活动近乎停滞、综合指数创十个月新低的情况,整体形势不容乐观,尤其是价格指标显著攀升。 标普全球市场情报首席商业经","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1774360200000,"gmtModify":1774388999653,"symbols":["LU0545562505.USD","LU1043141123.HKD","LU0426417589.USD","LU0426412945.USD","PMI","LU0994945656.USD"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/d9636da818824b878399390fe7469ecb"}],"repostCount":0,"viewCount":1718,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/546146669728224","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":2652,"displayRows":4,"foldSize":0,"authorId":"3524105790854316"}]},{"cardType":"TWEET","cardId":"TWEET.538747970069904","cardData":[{"tweetId":"538747970069904","author":{"authorId":"4143001014413252","idStr":"4143001014413252","name":"TimothyX","avatar":"https://static.tigerbbs.com/88095d545705c78d936c6451b3bf62a0","userType":1,"introduction":"","crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":58,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"与此同时,传统避险资产表现活跃:黄金价格上升2%,原油价格因供应担忧飙升7%,美元指数迎来数周来最强劲的一天,上升1%。 宏观经济数据:制造业复苏与通胀压力加剧 美股反弹的背后,有坚实的宏观数据支撑。2月份ISM制造业采购经理人指数(PMI)报52.4,连续第二个月高于50,标志制造业扩张,这是自2022年第四季度以来首次出现连续两个月扩张。","plainDigest":"与此同时,传统避险资产表现活跃:黄金价格上升2%,原油价格因供应担忧飙升7%,美元指数迎来数周来最强劲的一天,上升1%。 宏观经济数据:制造业复苏与通胀压力加剧 美股反弹的背后,有坚实的宏观数据支撑。2月份ISM制造业采购经理人指数(PMI)报52.4,连续第二个月高于50,标志制造业扩张,这是自2022年第四季度以来首次出现连续两个月扩张。","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1772549650899,"gmtModify":1772549659586,"symbols":["PMI"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":2019,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/538747970069904","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":302,"displayRows":4,"foldSize":0,"authorId":"4143001014413252"}]},{"cardType":"TWEET","cardId":"TWEET.530868339298512","cardData":[{"tweetId":"530868339298512","author":{"authorId":"4140741105005990","idStr":"4140741105005990","name":"易方达香港","avatar":"https://static.tigerbbs.com/59a81aa6e4bda20fb64c4b418d7856eb","userType":5,"introduction":"值得长期托付的世界级资产管理公司,我们执着于在长跑中胜出","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":1345,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"寰球易周谈 | 美国1月制造业PMI意外强劲扩张,墨西哥印度股市领跑全球","plainDigest":"寰球易周谈 | 美国1月制造业PMI意外强劲扩张,墨西哥印度股市领跑全球","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1770627498567,"gmtModify":1770627511557,"symbols":["PMI"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/6473c0e443480db3613acf08832ecff2","width":"750","height":"5750"}],"repostCount":0,"viewCount":47087,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/530868339298512","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":62,"displayRows":4,"foldSize":0,"authorId":"4140741105005990"}]},{"cardType":"TWEET","cardId":"TWEET.530869125374856","cardData":[{"tweetId":"530869125374856","author":{"authorId":"4140741105005990","idStr":"4140741105005990","name":"易方达香港","avatar":"https://static.tigerbbs.com/59a81aa6e4bda20fb64c4b418d7856eb","userType":5,"introduction":"值得长期托付的世界级资产管理公司,我们执着于在长跑中胜出","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":1345,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"美国1月制造业PMI意外强劲扩张,非制造业扩张放缓","digest":"重要讯息:01) 易方达精选策略系列—易方达(香港)精选债券基金(「子基金」)须受限于一般巿况波动及子基金资产的其他固有因素。因此,阁下须承担无法收回投资于子基金的本金或可能损失大部分或全部投资的风险。02) 子基金主要投资于以离岸人民币、美元、欧元或港元计价的投资级别债务证券组成的投资组合,旨在为子基金产生资本增值以外的稳定收入流,从而达致长期资本增长。可能承担a) 有关债务证券的风险(包括信贷风险、有关信贷评级的风险、信贷评级调低风险、利率风险、估值风险、波动性及流动性风险、主权/政府债务风险、低于投资级别或未获评级的债务证券的风险及与投资于具有吸收亏损特点的债务工具相关的风险), b)集中风险, c) 新兴市场风险, d) 外汇风险, e) 有关销售及回购协议的风险, f) 有关反向回购协议的风险, g)人民币货币风险及人民币计价类别风险, h) 对冲人民币计价类别风险, i) 可转换债券风险, j) 有关股本证券的风险, k) 欧元区及欧洲国家风险, l) 「点心」债券风险。03) 子基金可在守则准许的范围内投资于衍生工具作对冲或投资目的,而在不利情况下,其运用金融衍生工具可能变得无效及/或致使子基金蒙受重大损失。04) 子基金可从子基金的资本中支付分派。投资者应注意,从资本中支付分派相当于退回或提取投资者的部分原投资额或归属于该原投资额的任何资本收益,而该等分派可能导致有关单位的资产净值实时减少。对冲单位类别的分派金额及资产净值可能受到有关对冲单位类别的类别货币与子基金的基础货币的利率差异之不利影响,导致从资本中支付的分派金额有所增加,以及因此相对其他非对冲单位类别的资本流失更大。05) 除非中介人于销售基金时已向阁下解释经考虑阁下的财务情况、投资经验及目标后,此基金是适合阁下的,阁下不应投资在子基金。06)&nb","plainDigest":"重要讯息:01) 易方达精选策略系列—易方达(香港)精选债券基金(「子基金」)须受限于一般巿况波动及子基金资产的其他固有因素。因此,阁下须承担无法收回投资于子基金的本金或可能损失大部分或全部投资的风险。02) 子基金主要投资于以离岸人民币、美元、欧元或港元计价的投资级别债务证券组成的投资组合,旨在为子基金产生资本增值以外的稳定收入流,从而达致长期资本增长。可能承担a) 有关债务证券的风险(包括信贷风险、有关信贷评级的风险、信贷评级调低风险、利率风险、估值风险、波动性及流动性风险、主权/政府债务风险、低于投资级别或未获评级的债务证券的风险及与投资于具有吸收亏损特点的债务工具相关的风险), b)集中风险, c) 新兴市场风险, d) 外汇风险, e) 有关销售及回购协议的风险, f) 有关反向回购协议的风险, g)人民币货币风险及人民币计价类别风险, h) 对冲人民币计价类别风险, i) 可转换债券风险, j) 有关股本证券的风险, k) 欧元区及欧洲国家风险, l) 「点心」债券风险。03) 子基金可在守则准许的范围内投资于衍生工具作对冲或投资目的,而在不利情况下,其运用金融衍生工具可能变得无效及/或致使子基金蒙受重大损失。04) 子基金可从子基金的资本中支付分派。投资者应注意,从资本中支付分派相当于退回或提取投资者的部分原投资额或归属于该原投资额的任何资本收益,而该等分派可能导致有关单位的资产净值实时减少。对冲单位类别的分派金额及资产净值可能受到有关对冲单位类别的类别货币与子基金的基础货币的利率差异之不利影响,导致从资本中支付的分派金额有所增加,以及因此相对其他非对冲单位类别的资本流失更大。05) 除非中介人于销售基金时已向阁下解释经考虑阁下的财务情况、投资经验及目标后,此基金是适合阁下的,阁下不应投资在子基金。06)&nb","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1770627605915,"gmtModify":1770628271390,"symbols":["PMI"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":48139,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/530869125374856","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":4234,"displayRows":4,"foldSize":0,"authorId":"4140741105005990"}]},{"cardType":"TWEET","cardId":"TWEET.528032515643096","cardData":[{"tweetId":"528032515643096","author":{"authorId":"4100398390067080","idStr":"4100398390067080","name":"我是一只小明","avatar":"https://static.tigerbbs.com/e6b6e7059fb28620be411611cf7e25d9","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":291,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"1月制造业PMI:需求疲弱,但价格开始通胀","digest":"考虑到2026年开始正儿八经会有经济复苏的预期,所以部分宏观数据有必要恢复跟踪,尤其是制造业大国的制造业PMI。1月制造业PMI为49.3,较上月的50.1下降0.8重回萎缩,一年以来扩张区间(50以上)露头就秒。 细分数据(50以上扩张,50以下萎缩): 生产指数:51.7→50.6,制造业生产大部分时间保持扩张,只是扩张的速度时快时慢; 新订单:50.8→49.2,需求侧的订单指数每次进入扩张区间都感恩戴德,但大部分是露头就秒,且内需也出现明显回落; 新出口订单:49.0→47.8,出海需求持续处于萎靡状态; 原材料购进价格53.1→56.1,出厂价格48.9→50.6,原材料库存47.8→47.4,产成品库存48.2→48.6,原材料价格上涨自去年7月开始反馈在PMI数据上,1月显著加速,需要注意的是,出厂价格亦在1月被带动重回上涨,这是20个月来首次出现通胀信号,同时原材料库存在持续去化。 按企业规模看,大型企业50.8→50.3,中型企业49.8→48.7,小型企业48.6→47.4,大型企业在扩张中放缓,而中小型企业一直在水深中火热。 由于1月属于部分制造业的传统淡季,又有春节备货的干扰,数据借口很多,带来了PMI的又一次滑落,但需求不足仍然是主要矛盾,无论是旷日持久的外需订单萎缩,还是疲弱的内需,这是无法回避的。 1月PMI唯一的亮点是给PPI出力了,价格终于开始传导了!由于需求是偏弱的状态,大部分原因是原材料的炸裂涨价,但结果就是这个结果。至于本文开头提到的经济复苏预期,暂时还没有信号,需求疲弱+产品通胀,这似乎对应了另一个名词。 后续关注需求是否改善,价格传导是否持续。","plainDigest":"考虑到2026年开始正儿八经会有经济复苏的预期,所以部分宏观数据有必要恢复跟踪,尤其是制造业大国的制造业PMI。1月制造业PMI为49.3,较上月的50.1下降0.8重回萎缩,一年以来扩张区间(50以上)露头就秒。 细分数据(50以上扩张,50以下萎缩): 生产指数:51.7→50.6,制造业生产大部分时间保持扩张,只是扩张的速度时快时慢; 新订单:50.8→49.2,需求侧的订单指数每次进入扩张区间都感恩戴德,但大部分是露头就秒,且内需也出现明显回落; 新出口订单:49.0→47.8,出海需求持续处于萎靡状态; 原材料购进价格53.1→56.1,出厂价格48.9→50.6,原材料库存47.8→47.4,产成品库存48.2→48.6,原材料价格上涨自去年7月开始反馈在PMI数据上,1月显著加速,需要注意的是,出厂价格亦在1月被带动重回上涨,这是20个月来首次出现通胀信号,同时原材料库存在持续去化。 按企业规模看,大型企业50.8→50.3,中型企业49.8→48.7,小型企业48.6→47.4,大型企业在扩张中放缓,而中小型企业一直在水深中火热。 由于1月属于部分制造业的传统淡季,又有春节备货的干扰,数据借口很多,带来了PMI的又一次滑落,但需求不足仍然是主要矛盾,无论是旷日持久的外需订单萎缩,还是疲弱的内需,这是无法回避的。 1月PMI唯一的亮点是给PPI出力了,价格终于开始传导了!由于需求是偏弱的状态,大部分原因是原材料的炸裂涨价,但结果就是这个结果。至于本文开头提到的经济复苏预期,暂时还没有信号,需求疲弱+产品通胀,这似乎对应了另一个名词。 后续关注需求是否改善,价格传导是否持续。","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1769935161513,"gmtModify":1769935168356,"symbols":["PMI"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/5ebc8070e6f6e296d7313b44774a3e34","width":"1080","height":"680"}],"repostCount":0,"viewCount":2086,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/528032515643096","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":1195,"displayRows":4,"foldSize":0,"authorId":"4100398390067080"}]},{"cardType":"TWEET","cardId":"TWEET.528030664634736","cardData":[{"tweetId":"528030664634736","author":{"authorId":"4100398390067080","idStr":"4100398390067080","name":"我是一只小明","avatar":"https://static.tigerbbs.com/e6b6e7059fb28620be411611cf7e25d9","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":291,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"1月制造业PMI:需求疲弱,但价格开始通胀","digest":"考虑到2026年开始正儿八经会有经济复苏的预期,所以部分宏观数据有必要恢复跟踪,尤其是制造业大国的制造业PMI。1月制造业PMI为49.3,较上月的50.1下降0.8重回萎缩,一年以来扩张区间(50以上)露头就秒。 细分数据(50以上扩张,50以下萎缩): 生产指数:51.7→50.6,制造业生产大部分时间保持扩张,只是扩张的速度时快时慢; 新订单:50.8→49.2,需求侧的订单指数每次进入扩张区间都感恩戴德,但大部分是露头就秒,且内需也出现明显回落; 新出口订单:49.0→47.8,出海需求持续处于萎靡状态; 原材料购进价格53.1→56.1,出厂价格48.9→50.6,原材料库存47.8→47.4,产成品库存48.2→48.6,原材料价格上涨自去年7月开始反馈在PMI数据上,1月显著加速,需要注意的是,出厂价格亦在1月被带动重回上涨,这是20个月来首次出现通胀信号,同时原材料库存在持续去化。 按企业规模看,大型企业50.8→50.3,中型企业49.8→48.7,小型企业48.6→47.4,大型企业在扩张中放缓,而中小型企业一直在水深中火热。 由于1月属于部分制造业的传统淡季,又有春节备货的干扰,数据借口很多,带来了PMI的又一次滑落,但需求不足仍然是主要矛盾,无论是旷日持久的外需订单萎缩,还是疲弱的内需,这是无法回避的。 1月PMI唯一的亮点是给PPI出力了,价格终于开始传导了!由于需求是偏弱的状态,大部分原因是原材料的炸裂涨价,但结果就是这个结果。至于本文开头提到的经济复苏预期,暂时还没有信号,需求疲弱+产品通胀,这似乎对应了另一个名词。 后续关注需求是否改善,价格传导是否持续。","plainDigest":"考虑到2026年开始正儿八经会有经济复苏的预期,所以部分宏观数据有必要恢复跟踪,尤其是制造业大国的制造业PMI。1月制造业PMI为49.3,较上月的50.1下降0.8重回萎缩,一年以来扩张区间(50以上)露头就秒。 细分数据(50以上扩张,50以下萎缩): 生产指数:51.7→50.6,制造业生产大部分时间保持扩张,只是扩张的速度时快时慢; 新订单:50.8→49.2,需求侧的订单指数每次进入扩张区间都感恩戴德,但大部分是露头就秒,且内需也出现明显回落; 新出口订单:49.0→47.8,出海需求持续处于萎靡状态; 原材料购进价格53.1→56.1,出厂价格48.9→50.6,原材料库存47.8→47.4,产成品库存48.2→48.6,原材料价格上涨自去年7月开始反馈在PMI数据上,1月显著加速,需要注意的是,出厂价格亦在1月被带动重回上涨,这是20个月来首次出现通胀信号,同时原材料库存在持续去化。 按企业规模看,大型企业50.8→50.3,中型企业49.8→48.7,小型企业48.6→47.4,大型企业在扩张中放缓,而中小型企业一直在水深中火热。 由于1月属于部分制造业的传统淡季,又有春节备货的干扰,数据借口很多,带来了PMI的又一次滑落,但需求不足仍然是主要矛盾,无论是旷日持久的外需订单萎缩,还是疲弱的内需,这是无法回避的。 1月PMI唯一的亮点是给PPI出力了,价格终于开始传导了!由于需求是偏弱的状态,大部分原因是原材料的炸裂涨价,但结果就是这个结果。至于本文开头提到的经济复苏预期,暂时还没有信号,需求疲弱+产品通胀,这似乎对应了另一个名词。 后续关注需求是否改善,价格传导是否持续。","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1769934716235,"gmtModify":1769934733308,"symbols":["PMI"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/5ebc8070e6f6e296d7313b44774a3e34","width":"1080","height":"680"}],"repostCount":0,"viewCount":1696,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/528030664634736","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":1195,"displayRows":4,"foldSize":0,"authorId":"4100398390067080"}]},{"cardType":"TWEET","cardId":"TWEET.525815633309848","cardData":[{"tweetId":"525815633309848","author":{"authorId":"4140741105005990","idStr":"4140741105005990","name":"易方达香港","avatar":"https://static.tigerbbs.com/59a81aa6e4bda20fb64c4b418d7856eb","userType":5,"introduction":"值得长期托付的世界级资产管理公司,我们执着于在长跑中胜出","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":1345,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"美国1月PMI增速偏弱,消费显韧性但储蓄承压","digest":"重要讯息:01) 易方达精选策略系列—易方达(香港)精选债券基金(「子基金」)须受限于一般巿况波动及子基金资产的其他固有因素。因此,阁下须承担无法收回投资于子基金的本金或可能损失大部分或全部投资的风险。02) 子基金主要投资于以离岸人民币、美元、欧元或港元计价的投资级别债务证券组成的投资组合,旨在为子基金产生资本增值以外的稳定收入流,从而达致长期资本增长。可能承担a) 有关债务证券的风险(包括信贷风险、有关信贷评级的风险、信贷评级调低风险、利率风险、估值风险、波动性及流动性风险、主权/政府债务风险、低于投资级别或未获评级的债务证券的风险及与投资于具有吸收亏损特点的债务工具相关的风险), b)集中风险, c) 新兴市场风险, d) 外汇风险, e) 有关销售及回购协议的风险, f) 有关反向回购协议的风险, g)人民币货币风险及人民币计价类别风险, h) 对冲人民币计价类别风险, i) 可转换债券风险, j) 有关股本证券的风险, k) 欧元区及欧洲国家风险, l) 「点心」债券风险。03) 子基金可在守则准许的范围内投资于衍生工具作对冲或投资目的,而在不利情况下,其运用金融衍生工具可能变得无效及/或致使子基金蒙受重大损失。04) 子基金可从子基金的资本中支付分派。投资者应注意,从资本中支付分派相当于退回或提取投资者的部分原投资额或归属于该原投资额的任何资本收益,而该等分派可能导致有关单位的资产净值实时减少。对冲单位类别的分派金额及资产净值可能受到有关对冲单位类别的类别货币与子基金的基础货币的利率差异之不利影响,导致从资本中支付的分派金额有所增加,以及因此相对其他非对冲单位类别的资本流失更大。05) 除非中介人于销售基金时已向阁下解释经考虑阁下的财务情况、投资经验及目标后,此基金是适合阁下的,阁下不应投资在子基金。06)&nb","plainDigest":"重要讯息:01) 易方达精选策略系列—易方达(香港)精选债券基金(「子基金」)须受限于一般巿况波动及子基金资产的其他固有因素。因此,阁下须承担无法收回投资于子基金的本金或可能损失大部分或全部投资的风险。02) 子基金主要投资于以离岸人民币、美元、欧元或港元计价的投资级别债务证券组成的投资组合,旨在为子基金产生资本增值以外的稳定收入流,从而达致长期资本增长。可能承担a) 有关债务证券的风险(包括信贷风险、有关信贷评级的风险、信贷评级调低风险、利率风险、估值风险、波动性及流动性风险、主权/政府债务风险、低于投资级别或未获评级的债务证券的风险及与投资于具有吸收亏损特点的债务工具相关的风险), b)集中风险, c) 新兴市场风险, d) 外汇风险, e) 有关销售及回购协议的风险, f) 有关反向回购协议的风险, g)人民币货币风险及人民币计价类别风险, h) 对冲人民币计价类别风险, i) 可转换债券风险, j) 有关股本证券的风险, k) 欧元区及欧洲国家风险, l) 「点心」债券风险。03) 子基金可在守则准许的范围内投资于衍生工具作对冲或投资目的,而在不利情况下,其运用金融衍生工具可能变得无效及/或致使子基金蒙受重大损失。04) 子基金可从子基金的资本中支付分派。投资者应注意,从资本中支付分派相当于退回或提取投资者的部分原投资额或归属于该原投资额的任何资本收益,而该等分派可能导致有关单位的资产净值实时减少。对冲单位类别的分派金额及资产净值可能受到有关对冲单位类别的类别货币与子基金的基础货币的利率差异之不利影响,导致从资本中支付的分派金额有所增加,以及因此相对其他非对冲单位类别的资本流失更大。05) 除非中介人于销售基金时已向阁下解释经考虑阁下的财务情况、投资经验及目标后,此基金是适合阁下的,阁下不应投资在子基金。06)&nb","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1769399636500,"gmtModify":1769401884810,"symbols":["PMI"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":47477,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/525815633309848","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":3971,"displayRows":4,"foldSize":0,"authorId":"4140741105005990"}]},{"cardType":"TWEET","cardId":"TWEET.523355679691432","cardData":[{"tweetId":"523355679691432","author":{"authorId":"4192713077052572","idStr":"4192713077052572","name":"等也是一种策略 如何等在哪里等","avatar":"https://static.tigerbbs.com/120755ba038fdcb70c2bb1d2816ad8f1","userType":1,"introduction":"","crmLevel":4,"crmLevelSwitch":1,"individualDisplayBadges":[{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"星级创作者","description":"累计发表精华帖>=3(或有料帖>=10),且30天内发表过至少一篇精华帖(或4篇有料帖)并参与过评论","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.06.04","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":1}],"wearingBadges":[],"fanSize":679,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"📊 下周(1/19 - 23)重要经济指标与经济事件 📈 【1月19日(周一)】 美国市场休市(马丁·路德·金纪念日)🇺🇸 10:00 🇨🇳 中国 - 季度国内生产总值(GDP) 📈🔍 18:00 🇪🇺 欧元区 - 消费者物价调和指数(HICP) 🌐 达沃斯世界经济论坛 💼🏔️ 🌐 IMF世界经济展望 📊 【1月20日(周二)】 15:00 🇬🇧 英国 - 失业保险申请件数 📱 美国企业财报:Netflix[ $NFLX ] 【1月21日(周三)】 15:00 🇬🇧 英国 - 消费者物价指数(CPI) 23:00 🇺🇸 美国 - 成屋待完成销售指数 📱 美国企业财报: Johnson & Johnson[ $JNJ ] 【1月22日(周四)】 07:50 🇯🇵 日本 - 贸易统计 20:30 🇪🇺 欧元区 - 欧洲央行(ECB)理事会会议纪要 21:30 🇺🇸 美国 - 季度实际国内生产总值(GDP) 21:30 🇺🇸 美国 - 个人消费支出(PCE平减指数) 📈🔍 21:30 🇺🇸 美国 - 首次申请失业救济人数 📱 美国企业财报: 英特尔(Intel)[ $INTC ] 【1月23日(周五)】 07:30 🇯🇵 日本 - 全国消费者物价指数(CPI) 11:00 🇯🇵 日本 - 日本央行会议结束 💰🔍 13:00 🇸🇬 新加坡 - 消费者物价指数(CPI) 14:30 🇯🇵 日本 - 日本央行行长例行新闻发布会 🎙️💹 15:00 🇬🇧 英国 - 零售销售额 17:00 🇪🇺 欧元区 - 采购经理人指数(PMI) 17:30 🇬🇧 英国 - 采购经理人指数(PMI) 22:45 🇺🇸 美国 - 采购经理人指数(PMI) ※以上时间均为北京时间","plainDigest":"📊 下周(1/19 - 23)重要经济指标与经济事件 📈 【1月19日(周一)】 美国市场休市(马丁·路德·金纪念日)🇺🇸 10:00 🇨🇳 中国 - 季度国内生产总值(GDP) 📈🔍 18:00 🇪🇺 欧元区 - 消费者物价调和指数(HICP) 🌐 达沃斯世界经济论坛 💼🏔️ 🌐 IMF世界经济展望 📊 【1月20日(周二)】 15:00 🇬🇧 英国 - 失业保险申请件数 📱 美国企业财报:Netflix[ $NFLX ] 【1月21日(周三)】 15:00 🇬🇧 英国 - 消费者物价指数(CPI) 23:00 🇺🇸 美国 - 成屋待完成销售指数 📱 美国企业财报: Johnson & Johnson[ $JNJ ] 【1月22日(周四)】 07:50 🇯🇵 日本 - 贸易统计 20:30 🇪🇺 欧元区 - 欧洲央行(ECB)理事会会议纪要 21:30 🇺🇸 美国 - 季度实际国内生产总值(GDP) 21:30 🇺🇸 美国 - 个人消费支出(PCE平减指数) 📈🔍 21:30 🇺🇸 美国 - 首次申请失业救济人数 📱 美国企业财报: 英特尔(Intel)[ $INTC ] 【1月23日(周五)】 07:30 🇯🇵 日本 - 全国消费者物价指数(CPI) 11:00 🇯🇵 日本 - 日本央行会议结束 💰🔍 13:00 🇸🇬 新加坡 - 消费者物价指数(CPI) 14:30 🇯🇵 日本 - 日本央行行长例行新闻发布会 🎙️💹 15:00 🇬🇧 英国 - 零售销售额 17:00 🇪🇺 欧元区 - 采购经理人指数(PMI) 17:30 🇬🇧 英国 - 采购经理人指数(PMI) 22:45 🇺🇸 美国 - 采购经理人指数(PMI) ※以上时间均为北京时间","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1768748958248,"gmtModify":1768786448570,"symbols":["INTC","PMI","CPI","GDP","NFLX"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/f20cbecffb660f9eae11fbc9d85f1b17","width":"784","height":"1168"}],"repostCount":0,"viewCount":1564,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/523355679691432","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":946,"displayRows":4,"foldSize":0,"authorId":"4192713077052572"}]},{"cardType":"TWEET","cardId":"TWEET.522395336638968","cardData":[{"tweetId":"522395336638968","author":{"authorId":"3565306160488916","idStr":"3565306160488916","name":"锐信资本","avatar":"https://static.tigerbbs.com/6f3b92a510cef2a3a3213c05cf857b27","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":805,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"美国两个制造业PMI数据的差异","digest":"","plainDigest":"","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1768561329474,"gmtModify":1768568664523,"symbols":["PMI"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":1200,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":true,"video":{"poster":"https://static.tigerbbs.com/2a98e177d155b4240e68a614d70d782e","url":"https://1254107296.vod2.myqcloud.com/73ba5544vodgzp1254107296/0d45bd3d5145403713059337156/Jam49WPzaNEA.mp4","uuid":"9a01eb45172548a0a1c6c76a09addaa9"},"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/522395336638968","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":0,"displayRows":4,"foldSize":0,"authorId":"3565306160488916"}]}],"size":10},"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"21351490","market":"us","labels":[],"media":"sec.gov","original_id":"AN209550726000002-PMI","pdf_url":"","pub_time":1780459200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"PMI","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2030617/000209550726000002/0002095507-26-000002-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000209550726000002/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE5RTnJkrBLWdp9sjU","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-06-03 12:00","pubTimestamp":1780459200,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21342449","market":"us","labels":[],"media":"sec.gov","original_id":"AN143774926019099-PMI","pdf_url":"","pub_time":1780372800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"PMI","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926019099/0001437749-26-019099-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926019099/pmi20260601_8k.htm","primary":true,"translateUrl":"","linkName":"pmi20260601_8k.htm","type":"8-K","id":"NTFILEBTgkR7Fc7zCtSNkk","market":"us","size":23338}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-06-02 12:00","pubTimestamp":1780372800,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","summary_zh":"第5.02项:董事或某些高级职员的离职;选举董事;若干人员的委任:若干人员的补偿安排","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21339062","market":"us","labels":[],"media":"sec.gov","original_id":"AN209550726000001-PMI","pdf_url":"","pub_time":1780286400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"PMI","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2030617/000209550726000001/0002095507-26-000001-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000209550726000001/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILEHBP1gGCD1QRZmvwU","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-06-01 12:00","pubTimestamp":1780286400,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21328096","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912626005779-PMI","pdf_url":"","pub_time":1780027200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"PMI","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626005779/0001829126-26-005779-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626005779/picardmedical_ex99-1.htm","primary":true,"translateUrl":"","linkName":"picardmedical_ex99-1.htm","type":"EX-99.1","id":"NTFILEBBCbrcZUZHW5TvSD","market":"us","size":24470},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626005779/picardmedical_8k.htm","primary":false,"translateUrl":"","linkName":"picardmedical_8k.htm","type":"8-K","id":"NTFILE9r82GiRdMjnc3ULK","market":"us","size":26311}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-05-29 12:00","pubTimestamp":1780027200,"title_zh":"Form 8-K - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第7.01项:法规FD披露;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21297974","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912626005568-PMI","pdf_url":"","pub_time":1779394519000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"PMI","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2030617/0001829126-26-005568-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626005568/picardmedical_ex99-1.htm","primary":true,"translateUrl":"","linkName":"picardmedical_ex99-1.htm","type":"EX-99.1","id":"NTFILE4D7x5EBsJ8nqTpEJ","market":"us","size":19006},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626005568/picardmedical_8k.htm","primary":false,"translateUrl":"","linkName":"picardmedical_8k.htm","type":"8-K","id":"NTFILEBGErrxyzgqmqxQtd","market":"us","size":32212}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-05-22 04:15","pubTimestamp":1779394519,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第2.02项:经营业绩和财务状况;第3.01项:除牌通知或未能符合持续上市规则或标准;转让上市;第7.01项:法规FD披露;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21290399","market":"us","labels":[],"media":"sec.gov","original_id":"AN143774926017949-PMI","pdf_url":"","pub_time":1779249600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1 - General form for registration of securities under the Securities Act of 1933","symbol":"PMI","title":"Form S-1 - General form for registration of securities under the Securities Act of 1933","titleType":"招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926017949/0001437749-26-017949-index.htm","us_notice_code":"Form S-1","us_title_en":"Form S-1 - General form for registration of securities under the Securities Act of 1933","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM S-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926017949/pmi20260519_s1.htm","primary":true,"translateUrl":"","linkName":"pmi20260519_s1.htm","type":"S-1","id":"NTFILEFkCpnkE5pt5213wW","market":"us","size":3771561},{"description":"EXHIBIT 5.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926017949/ex_965311.htm","primary":false,"translateUrl":"","linkName":"ex_965311.htm","type":"EX-5.1","id":"NTFILE4himgoaACLMCf8uC","market":"us","size":8073},{"description":"EXHIBIT 23.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926017949/ex_965801.htm","primary":false,"translateUrl":"","linkName":"ex_965801.htm","type":"EX-23.1","id":"NTFILEA9yWmjV83SyUCiEk","market":"us","size":3295},{"description":"EXHIBIT FILING FEES","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926017949/ex_965312.htm","primary":false,"translateUrl":"","linkName":"ex_965312.htm","type":"EX-FILING FEES","id":"NTFILE8FvRSsxf5yaFemHU","market":"us","size":27982},{"description":"","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926017949/c1.jpg","primary":false,"translateUrl":"","linkName":"c1.jpg","type":"GRAPHIC","id":"NTFILE9F5KTxb8nAy4q8FQ","market":"us","size":53384},{"description":"","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926017949/criteria.jpg","primary":false,"translateUrl":"","linkName":"criteria.jpg","type":"GRAPHIC","id":"NTFILE9pjTYZnjqJ2Gda5z","market":"us","size":143674},{"description":"","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926017949/driver.jpg","primary":false,"translateUrl":"","linkName":"driver.jpg","type":"GRAPHIC","id":"NTFILE73HvTSk2FkVPMuXY","market":"us","size":79491},{"description":"","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926017949/freedom.jpg","primary":false,"translateUrl":"","linkName":"freedom.jpg","type":"GRAPHIC","id":"NTFILE66McJYMzyRzb1z8n","market":"us","size":45626},{"description":"","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926017949/heart.jpg","primary":false,"translateUrl":"","linkName":"heart.jpg","type":"GRAPHIC","id":"NTFILE5xPrT2p9pkd2bz4n","market":"us","size":100994}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"招股说明书","pubTime":"2026-05-20 12:00","pubTimestamp":1779249600,"title_zh":"Form S-1 - General form for registration of securities under the Securities Act of 1933","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21268507","market":"us","labels":[],"media":"sec.gov","original_id":"AN143774926017342-PMI","pdf_url":"","pub_time":1778817600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"PMI","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926017342/0001437749-26-017342-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926017342/pmi20260331_10q.htm","primary":true,"translateUrl":"","linkName":"pmi20260331_10q.htm","type":"10-Q","id":"NTFILEEf6EtavdAsYe282W","market":"us","size":1337846},{"description":"EXHIBIT 31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926017342/ex_923205.htm","primary":false,"translateUrl":"","linkName":"ex_923205.htm","type":"EX-31.1","id":"NTFILEBxXpBcRvprF1qDee","market":"us","size":13223},{"description":"EXHIBIT 31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926017342/ex_923206.htm","primary":false,"translateUrl":"","linkName":"ex_923206.htm","type":"EX-31.2","id":"NTFILEGXrTmmQmuL8Cf7fz","market":"us","size":13087},{"description":"EXHIBIT 32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926017342/ex_923207.htm","primary":false,"translateUrl":"","linkName":"ex_923207.htm","type":"EX-32.1","id":"NTFILE9H8Nywpw9HfAtHoo","market":"us","size":5388},{"description":"EXHIBIT 32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926017342/ex_923208.htm","primary":false,"translateUrl":"","linkName":"ex_923208.htm","type":"EX-32.2","id":"NTFILE8Pq91783UzuuWk5W","market":"us","size":5413}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2026-05-15 12:00","pubTimestamp":1778817600,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21268506","market":"us","labels":[],"media":"sec.gov","original_id":"AN143774926017171-PMI","pdf_url":"","pub_time":1778817600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]","symbol":"PMI","title":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]","titleType":"[修订]年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926017171/0001437749-26-017171-index.htm","us_notice_code":"Form 10-K/A","us_title_en":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 10-K/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926017171/pmi20251231_10ka.htm","primary":true,"translateUrl":"","linkName":"pmi20251231_10ka.htm","type":"10-K/A","id":"NTFILE9Aa4Xqi4WQessAce","market":"us","size":63713},{"description":"EXHIBIT 31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926017171/ex_963062.htm","primary":false,"translateUrl":"","linkName":"ex_963062.htm","type":"EX-31.1","id":"NTFILEFvdANQKe2qWgy3Cn","market":"us","size":9030},{"description":"EXHIBIT 31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926017171/ex_963063.htm","primary":false,"translateUrl":"","linkName":"ex_963063.htm","type":"EX-31.2","id":"NTFILEASc7p8ZJXe8Q29Pv","market":"us","size":9193}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"[Rev.]Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"[修订]年度报告","pubTime":"2026-05-15 12:00","pubTimestamp":1778817600,"title_zh":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21241288","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912626004960-PMI","pdf_url":"","pub_time":1778472000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"PMI","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004960/0001829126-26-004960-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 1.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004960/picardmedical_ex1-1.htm","primary":true,"translateUrl":"","linkName":"picardmedical_ex1-1.htm","type":"EX-1.1","id":"NTFILE3jFht8eCGu2YHdsa","market":"us","size":58375},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004960/picardmedical_8k.htm","primary":false,"translateUrl":"","linkName":"picardmedical_8k.htm","type":"8-K","id":"NTFILECf5HthxDT4UCGBKC","market":"us","size":38189},{"description":"EXHIBIT 4.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004960/picardmedical_ex4-1.htm","primary":false,"translateUrl":"","linkName":"picardmedical_ex4-1.htm","type":"EX-4.1","id":"NTFILEHNBjQSTSj3gqzfms","market":"us","size":99934},{"description":"EXHIBIT 4.2","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004960/picardmedical_ex4-2.htm","primary":false,"translateUrl":"","linkName":"picardmedical_ex4-2.htm","type":"EX-4.2","id":"NTFILEGYP5D2grxe4bnoZc","market":"us","size":99938},{"description":"EXHIBIT 4.3","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004960/picardmedical_ex4-3.htm","primary":false,"translateUrl":"","linkName":"picardmedical_ex4-3.htm","type":"EX-4.3","id":"NTFILE3aFqM12mDLWNkViH","market":"us","size":97490},{"description":"EXHIBIT 5.1","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004960/picardmedical_ex5-1.htm","primary":false,"translateUrl":"","linkName":"picardmedical_ex5-1.htm","type":"EX-5.1","id":"NTFILEE3CFWZ2KEvVQR4k5","market":"us","size":10023},{"description":"EXHIBIT 10.1","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004960/picardmedical_ex10-1.htm","primary":false,"translateUrl":"","linkName":"picardmedical_ex10-1.htm","type":"EX-10.1","id":"NTFILE3EjLuUjApWFTBuSw","market":"us","size":276961},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004960/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILEBbwPWp581hBzzBes","market":"us","size":23408},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004960/ex5-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_002.jpg","type":"GRAPHIC","id":"NTFILEDVKHK6ZRqEF46ZuT","market":"us","size":5610}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-05-11 12:00","pubTimestamp":1778472000,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项:签订重大最终协议;第3.01项:除牌通知或未能符合持续上市规则或标准;转让上市;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21210972","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912626004529-PMI","pdf_url":"","pub_time":1777953600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"PMI","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004529/0001829126-26-004529-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 4.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004529/picardmedical_ex4-1.htm","primary":true,"translateUrl":"","linkName":"picardmedical_ex4-1.htm","type":"EX-4.1","id":"NTFILEFxRvmruYxjjhGMAr","market":"us","size":115552},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004529/picardmedical_8k.htm","primary":false,"translateUrl":"","linkName":"picardmedical_8k.htm","type":"8-K","id":"NTFILEEyqLzyfdEjfgB1oA","market":"us","size":34139},{"description":"EXHIBIT 10.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004529/picardmedical_ex10-1.htm","primary":false,"translateUrl":"","linkName":"picardmedical_ex10-1.htm","type":"EX-10.1","id":"NTFILEXkUhhg1QrMGyY9sb","market":"us","size":44231},{"description":"EXHIBIT 99.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004529/picardmedical_ex99-1.htm","primary":false,"translateUrl":"","linkName":"picardmedical_ex99-1.htm","type":"EX-99.1","id":"NTFILEDsXggBnJn9WK4B6z","market":"us","size":14024},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004529/ex99-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILEGjx7XLHVqX2rkRxf","market":"us","size":11523}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-05-05 12:00","pubTimestamp":1777953600,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项:签订重大最终协议;第3.02项:未经登记的股本证券销售;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21347542","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912626004417-PMI","pdf_url":"","pub_time":1777898760000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"PMI","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2030617/0001829126-26-004417-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004417/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEDm9RSNWp7rb3jz5i","market":"us","size":6396}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2026-05-04 20:46","pubTimestamp":1777898760,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21347505","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912626004415-PMI","pdf_url":"","pub_time":1777898407000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"PMI","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2030617/0001829126-26-004415-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004415/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEEmGYvc3xreKcU6xq","market":"us","size":9206}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2026-05-04 20:40","pubTimestamp":1777898407,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21201816","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912626004376-PMI","pdf_url":"","pub_time":1777608000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"PMI","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[修订]招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004376/0001829126-26-004376-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-1/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004376/picardmedical_s1a.htm","primary":true,"translateUrl":"","linkName":"picardmedical_s1a.htm","type":"S-1/A","id":"NTFILE6J8WVxCHS8AUY8As","market":"us","size":2603264},{"description":"EXHIBIT 4.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004376/picardmedical_ex4-1.htm","primary":false,"translateUrl":"","linkName":"picardmedical_ex4-1.htm","type":"EX-4.1","id":"NTFILEE1iSycnaW2J3kfGL","market":"us","size":99260},{"description":"EXHIBIT 4.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004376/picardmedical_ex4-2.htm","primary":false,"translateUrl":"","linkName":"picardmedical_ex4-2.htm","type":"EX-4.2","id":"NTFILED6yNCYTg6Rs3yxQK","market":"us","size":99275},{"description":"EXHIBIT 5.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004376/picardmedical_ex5-1.htm","primary":false,"translateUrl":"","linkName":"picardmedical_ex5-1.htm","type":"EX-5.1","id":"NTFILEFPducSXQjaSwv2bJ","market":"us","size":9918},{"description":"EXHIBIT 10.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004376/picardmedical_ex10-1.htm","primary":false,"translateUrl":"","linkName":"picardmedical_ex10-1.htm","type":"EX-10.1","id":"NTFILE5D2NJVu8Y1oAB1Yi","market":"us","size":277049},{"description":"EXHIBIT 107","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004376/picardmedical_ex107.htm","primary":false,"translateUrl":"","linkName":"picardmedical_ex107.htm","type":"EX-99.107","id":"NTFILEANSQvVzFjfZLBaD3","market":"us","size":26169},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004376/img_001.jpg","primary":false,"translateUrl":"","linkName":"img_001.jpg","type":"GRAPHIC","id":"NTFILEHDh5PNpmubNFncZy","market":"us","size":169856},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004376/img_002.jpg","primary":false,"translateUrl":"","linkName":"img_002.jpg","type":"GRAPHIC","id":"NTFILE9nE2tcVF488jQUnQ","market":"us","size":108067},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004376/img_003.jpg","primary":false,"translateUrl":"","linkName":"img_003.jpg","type":"GRAPHIC","id":"NTFILEG2vsgEw8CQchpLgW","market":"us","size":47479},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004376/img_004.jpg","primary":false,"translateUrl":"","linkName":"img_004.jpg","type":"GRAPHIC","id":"NTFILECMu2RKZAqKZb5FEs","market":"us","size":106195},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004376/img_005.jpg","primary":false,"translateUrl":"","linkName":"img_005.jpg","type":"GRAPHIC","id":"NTFILEAao39JoJEKTka9ri","market":"us","size":54144},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004376/img_006.jpg","primary":false,"translateUrl":"","linkName":"img_006.jpg","type":"GRAPHIC","id":"NTFILE3TjrtzqjReSQpLeS","market":"us","size":104806},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004376/img_007.jpg","primary":false,"translateUrl":"","linkName":"img_007.jpg","type":"GRAPHIC","id":"NTFILE6YvVBzvzfV7kWSb1","market":"us","size":67767},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004376/img_008.jpg","primary":false,"translateUrl":"","linkName":"img_008.jpg","type":"GRAPHIC","id":"NTFILECAKcb3qzJHPedQZ2","market":"us","size":47479},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004376/img_009.jpg","primary":false,"translateUrl":"","linkName":"img_009.jpg","type":"GRAPHIC","id":"NTFILECZpuggXpSG1RxXgN","market":"us","size":106195},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004376/img_010.jpg","primary":false,"translateUrl":"","linkName":"img_010.jpg","type":"GRAPHIC","id":"NTFILEF5dE8QPThth76gBD","market":"us","size":54144},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004376/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILE86Qi2A6nx8mjS4qG","market":"us","size":23408},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004376/ex5-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_002.jpg","type":"GRAPHIC","id":"NTFILE88juVH5xQ93dd2ne","market":"us","size":5610}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[修订]招股说明书","pubTime":"2026-05-01 12:00","pubTimestamp":1777608000,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21347527","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912626004278-PMI","pdf_url":"","pub_time":1777578996000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"PMI","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2030617/0001829126-26-004278-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004278/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEHzPfWJH58mUeW7rf","market":"us","size":9687}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2026-05-01 03:56","pubTimestamp":1777578996,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21347516","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912626004277-PMI","pdf_url":"","pub_time":1777578929000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"PMI","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2030617/0001829126-26-004277-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004277/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE45Cat6j4nbVkszTN","market":"us","size":11536}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2026-05-01 03:55","pubTimestamp":1777578929,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.picardmedical.com","stockEarnings":[{"period":"1week","weight":0.9299},{"period":"1month","weight":-0.3844},{"period":"3month","weight":-0.7632},{"period":"6month","weight":-0.9268},{"period":"1year","weight":-0.9325},{"period":"ytd","weight":-0.8457}],"compareEarnings":[{"period":"1week","weight":0.012},{"period":"1month","weight":0.054},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.1098},{"period":"1year","weight":0.2815},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Picard Medical, Inc.于2021年4月8日在特拉华州注册成立。该公司作为一家控股公司,拥有SynCardia Systems, LLC(“SynCardia”)100%的权益。业务运营由SynCardia进行。SynCardia是一家医疗技术公司,生产和销售唯一经美国食品和药物管理局(“FDA”)和加拿大卫生部批准的全人工心脏(“TAH”),它完全取代了衰竭的人类心脏的功能。SynCardia还在医疗技术方面进行更多的研究和进步,包括下一代完全可植入和无驱动的心脏—Emperor TAH。","exchange":"AMEX","name":"Picard Medical, Inc.","nameEN":"Picard Medical, Inc."},"aProfile":null}}}